Dementia
Stories
-
Results posted for dexmedetomidine study in dementia agitation
Results for this study were first posted on ClinicalTrials.gov on October 1, 2026. The study, a Phase 3, randomized, double-blind, placebo-controlled trial, enrolled 13 participants and was terminated.